In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
BioAtla Inc (NASDAQ: BCAB) closed the day trading at $1.56 down -8.77% from the previous closing price of $1.71. In other words, the price has decreased by -$8.77 from its previous closing price. On the day, 1.73 million shares were traded. BCAB stock price reached its highest trading level at $1.775 during the session, while it also had its lowest trading level at $1.5.
Ratios:
For a better understanding of BCAB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.11 and its Current Ratio is at 3.11. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.00.
On September 15, 2022, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $17.
Credit Suisse Downgraded its Outperform to Neutral on May 05, 2022, whereas the target price for the stock was revised from $35 to $5.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 26 ’23 when MCBRINN SYLVIA bought 4,000 shares for $2.33 per share. The transaction valued at 9,320 led to the insider holds 15,125 shares of the business.
SHORT JAY M PHD bought 50,000 shares of BCAB for $106,910 on Dec 20 ’23. The Chief Executive Officer now owns 1,439,283 shares after completing the transaction at $2.14 per share. On Dec 19 ’23, another insider, STEINMAN LAWRENCE, who serves as the Director of the company, bought 20,000 shares for $2.05 each. As a result, the insider paid 41,048 and bolstered with 38,459 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BCAB now has a Market Capitalization of 75419136 and an Enterprise Value of 20154094. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.25 while its Price-to-Book (P/B) ratio in mrq is 3.28. Its current Enterprise Value per Revenue stands at 1.832 whereas that against EBITDA is -0.237.
Stock Price History:
Over the past 52 weeks, BCAB has reached a high of $4.02, while it has fallen to a 52-week low of $1.14. The 50-Day Moving Average of the stock is -18.52%, while the 200-Day Moving Average is calculated to be -27.11%.
Shares Statistics:
Over the past 3-months, BCAB traded about 1.23M shares per day on average, while over the past 10 days, BCAB traded about 1452250 shares per day. A total of 48.08M shares are outstanding, with a floating share count of 39.02M. Insiders hold about 19.30% of the company’s shares, while institutions hold 32.54% stake in the company. Shares short for BCAB as of 1730332800 were 4868885 with a Short Ratio of 3.97, compared to 1727654400 on 4466935. Therefore, it implies a Short% of Shares Outstanding of 4868885 and a Short% of Float of 11.26.
